A1 Refereed original research article in a scientific journal

Hyperinflammation of chronic granulomatous disease is abolished by NOX2 reconstitution in macrophages and dendritic cells




AuthorsDeffert C, Carnesecchi S, Yuan HP, Rougemont AL, Kelkka T, Holmdahl R, Krause KH, Schappi MG

PublisherWILEY-BLACKWELL

Publication year2012

JournalJournal of Pathology

Journal name in sourceJOURNAL OF PATHOLOGY

Journal acronymJ PATHOL

Number in series3

Volume228

Issue3

First page 341

Last page350

Number of pages10

ISSN0022-3417

DOIhttps://doi.org/10.1002/path.4061


Abstract
Chronic granulomatous disease (CGD), caused by a lack of reactive oxygen species (ROS) generation by the phagocyte NADPH oxidase NOX2, leads to massively increased inflammatory responses. In order to identify the type of phagocyte which requires NOX2 activity to limit inflammation, we investigated mice with a loss of function mutation in the Ncf1 gene coding for the p47(phox) subunit of NOX2 and mice with transgenic rescue of Ncf1 under control of the CD68 promoter. To induce CGD hyperinflammation, different mouse genotypes were injected intradermally with beta-glucan. Ncf1 mutant mice showed massive and prolonged hyperinflammation. Hyperinflammatory lesions were characterized by persistent neutrophilic infiltration, along with ulceration and necrosis. In contrast, in CD68 promoter rescue mice inflammation resolved within days, as seen in wild-type animals. Measurements of ROS in rescue mice demonstrated functional NOX2 in mononuclear phagocytes (macrophages and dendritic cells) but not in neutrophils. This absence of NOX2 function was also confirmed in inflammatory tissue neutrophils. Lack of functional NOX2 in mononuclear phagocytes increased the secretion of IL-1 beta at early time points and of IL-6 and TNFa at later time points. Thus, CGD hyperinflammation is a redox dysregulation in mononuclear phagocytes, demonstrating a cell type-specific anti-inflammatory function of NOX2. Copyright (c) 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.



Last updated on 2024-26-11 at 19:58